Dexlansoprazole Market Report 2024 (Global Edition)

Global Dexlansoprazole Market Report 2024 Market Size Split by Product Type (30 mg, 60 mg), by Application (Gastroesophageal Reflux Disease, Heal Erosive Esophagitis), by Patient Demographics (Adults,...

Dexlansoprazole Market Report Description

We have various report editions of Dexlansoprazole Market, hence please contact our sales team and author directly to obtain/purchase a desired Edition eg, Global Edition, Regional Edition, Country Specific Report Edition, Company Profiles, Forecast Edition, etc. Request for your Free Sample PDF/Online Access.

Competitive Landscape of the Dexlansoprazole Market

Key players deploy strategic initiatives such as product innovations, partnerships, and mergers. Companies prioritize R&D to introduce cutting-edge reagents, ensuring a competitive edge. Robust distribution networks and adherence to quality standards amplify market presence, fostering an environment where agility and innovation define industry leaders.

Top Companies Market Share in Dexlansoprazole Industry: (In no particular order of Rank)

• Takeda
• Cardinal Health
• Suzhou Homesun Pharmaceutical
• Frontida
• Zhendong Group
• Ouya Pharmaceutical
• Heron Pharmaceutical
• Sailong
• Confidential Data
• Access The Paid Version
• Data Hidden

*List of Second Tier Companies, List of Third Tier/ Start-up Companies (Inquire with sales executive) Request Any Company Profile for Preview Purpose OR Data Validation!

If any Company(ies) of your interest has/have not been disclosed in the above list then please let us know the same so that we will check the data availability in our database and provide you the confirmation or include it in the final deliverables.

Regional Analysis  of the Dexlansoprazole Market

Which Region Dominates the Dexlansoprazole Market in 2024?

According to Cognitive Market Research, North America dominated the market in 2024 and accounted for around 40% of the global revenue. Due to factors like growing awareness of gastroesophageal reflux disease (GERD), increased need for efficient treatment choices, and improvements in healthcare infrastructure, the Dexlansoprazole market in North America is expanding rapidly. Due to its extended-release composition and effectiveness in treating GERD symptoms, dexlansoprazole is becoming increasingly popular in the area. It is a top option for consumers and healthcare professionals.

Which Region is Expanding at the Fastest CAGR?

The Europe region is witnessing an increase in the sales of reagents. The market for dexlansoprazole is expanding significantly in Europe due to reasons such as the growing prevalence of GERD, the increased use of cutting-edge treatment alternatives, and rising healthcare expenditures. Dexlansoprazole is becoming increasingly popular in Europe because of its extended-release formulation and ability to treat GERD symptoms effectively. Both patients and healthcare professionals find it to be a highly preferred option.

The current report Scope analyzes Dexlansoprazole Market on 5 major region Split (In case you wish to acquire a specific region edition (more granular data) or any country Edition data then please write us on info@cognitivemarketresearch.com

• North America (United States, Canada, Mexico)
• Europe (United Kingdom, France, Germany, Italy, Russia, Spain, Sweden, Denmark, Netherlands, Switzerland, Belgium)
• Asia-Pacific (China, Japan, Korea, India, Australia, Philippines, Singapore, Malaysia, Thailand, Indonesia, Rest of APAC)
• South America (Brazil, Argentina, Colombia, Peru, Chile, Rest of South America)
• Middle East and Africa (Saudi Arabia, Turkey, Nigeria, UAE, Egypt, South Africa, GCC Countries, Rest of MEA)

The above graph is for illustrative purposes only.

North America Dexlansoprazole Market

According to Cognitive Market Research, the global Dexlansoprazole market size was estimated at USD XX Million out of which North America held the major market of more than 40% of the global revenue with a market size of USD XX million in 2024 and will grow at a compound annual growth rate (CAGR) 4.2% from 2024 to 2031. The demand for efficient treatment choices and growing awareness of gastroesophageal reflux disease (GERD) are two factors driving the steady rise of the dexlansoprazole market in North America. The aging population is a major factor in this growth since they are more likely to experience difficulties from GERD and hence need long-term therapy with drugs like Dexlansoprazole. The availability of extended-release formulations and improvements in healthcare infrastructure have also fueled market expansion. In summary, increased awareness, changing demographics, and continuous innovation have contributed to the growth of the Dexlansoprazole market in North America, establishing it as a key participant in the treatment of GERD in the area.

Country Analysis

• According to Cognitive Market Research, the US had a major share in the Dexlansoprazole market with a market size of USD XX million in 2024 and is projected to grow at a CAGR of 4.0% during the forecast period. The demand is amplified by the nation's high prevalence of GERD. 
• The Canada Dexlansoprazole market had a market share of USD XX million in 2024 and is projected to grow at a CAGR of 5.0% during the forecast period. Canada's rising changing dietary habits.
• The Mexico Dexlansoprazole market is projected to witness growth at a CAGR of 4.7% during the forecast period with a market size of USD XX million in 2024.

Europe Dexlansoprazole Market

According to Cognitive Market Research, with a market value of USD XX million in 2024 and projected to expand at a compound annual growth rate (CAGR) of 4.5% from 2024 to 2031. Europe accounted for a share of over 30% of the global market size of USD XX million. Growing rates of gastroesophageal reflux disease (GERD) and an aging population are driving substantial growth in the dexlansoprazole market in Europe. The demand for long-term therapy options for GERD is increasing in Europe. One such option is Dexlansoprazole, which comes in extended-release formulations that provide continuous symptom relief. The elderly population is a major factor driving market expansion since they are more vulnerable to issues connected to GERD. The industry is also growing as a result of improvements in healthcare infrastructure and rising healthcare costs. To sum up, Dexlansoprazole plays a significant role in the European market by offering efficient GERD management options in the face of changing healthcare and demographic trends.

• The United Kingdom Dexlansoprazole market had a market share of USD XX million in 2024 and is projected to grow at a CAGR of 5.3% during the forecast period. In the UK, Dexlansoprazole sales witness an upswing due to the nation's increasing healthcare expenditure. 
• The France Dexlansoprazole market is projected to witness growth at a CAGR of 3.7% during the forecast period with a market size of USD XX million in 2024.
• According to Cognitive Market Research, the Germany Dexlansoprazole market size was valued at USD XX million in 2024 and is projected to grow at a CAGR of 4.7% during the forecast period. In Germany, Dexlansoprazole sales surge due to the nation's expanding healthcare infrastructure. 
• The Italy Dexlansoprazole market is projected to witness growth at a CAGR of 3.9% during the forecast period with a market size of USD XX million in 2024.
• The Russia Dexlansoprazole market is projected to witness growth at a CAGR of 3.5% during the forecast period with a market size of USD XX million in 2024.
• The Spain Dexlansoprazole market is projected to witness growth at a CAGR of 3.6% during the forecast period with a market size of USD XX million in 2024.
• The Luxembourg Dexlansoprazole market is projected to witness growth at a CAGR of 4.6% during the forecast period with a market size of USD XX million in 2024.
• The Portugal Dexlansoprazole market is projected to witness growth at a CAGR of 4.3% during the forecast period with a market size of USD XX million in 2024.
• The Greece Dexlansoprazole market is projected to witness growth at a CAGR of 4.8% during the forecast period with a market size of USD XX million in 2024.
• Rest of Europe Dexlansoprazole market is projected to witness growth at a CAGR of 3.2% during the forecast period with a market size of USD XX million in 2024.

Asia Pacific Dexlansoprazole Market

According to Cognitive Market Research, the global Dexlansoprazole market size was estimated at USD XX Million out of which Asia Pacific held the market of around 23% of the global revenue with a market size of USD XX million in 2024 and will grow at a compound annual growth rate (CAGR) of 8.0% from 2024 to 2031. The Asia Pacific region's dexlansoprazole market is growing significantly, propelled by rising rates of gastroesophageal reflux disease (GERD) and a fast growing senior population. There is an increasing need for efficient treatments like Dexlansoprazole, which provides extended-release formulations for long-lasting symptom relief, as GERD awareness grows and lifestyles shift. Growing at a substantial rate is the senior population, which is vulnerable to complications from GERD. Furthermore, the expanding market for Dexlansoprazole in the Asia Pacific area is facilitated by the region's improved healthcare infrastructure and growing healthcare spending. throughout conclusion, despite changing healthcare environments and demographics, dextlansoprazole is essential for treating GERD throughout the Asia Pacific region.

• According to Cognitive Market Research, the China Dexlansoprazole market size was valued at USD XX million in 2024 and is projected to grow at a CAGR of 7.5% during the forecast period. Dexlansoprazole sales surge in China due to the nation's rapid growing awareness about gastrointestinal health.
• The Japan Dexlansoprazole market is projected to witness growth at a CAGR of 6.5% during the forecast period with a market size of USD XX million in 2024.
• The India Dexlansoprazole market had a market share of USD XX million in 2024 and is projected to grow at a CAGR of 9.8% during the forecast period. The demand is augmented by India's increasing favorable regulatory policies.
• The South Korea Dexlansoprazole market is projected to witness growth at a CAGR of 7.1% during the forecast period with a market size of USD XX million in 2024.
• The Australia Dexlansoprazole market is projected to witness growth at a CAGR of 7.7% during the forecast period with a market size of USD XX million in 2024.
• The South East Asia Dexlansoprazole market is projected to witness growth at a CAGR of 9.0% during the forecast period with a market size of USD XX million in 2024.
• The Rest of Asia Pacific Dexlansoprazole market is projected to witness growth at a CAGR of 7.8% during the forecast period with a market size of USD XX million in 2024.

South America Dexlansoprazole Market

According to Cognitive Market Research, the global Dexlansoprazole market size was estimated at USD XX Million out of which Latin America market of more than 5% of the global revenue with a market size of USD XX million in 2024 and will grow at a compound annual growth rate (CAGR) of 5.4% from 2024 to 2031. The market for dexlansoprazole is steadily expanding in Latin America because to a rise in the prevalence of gastroesophageal reflux disease (GERD) and increased knowledge of its treatment. The extended-release version of dexlansoprazole appeals to a wide spectrum of patients by providing an efficient means of long-term symptom alleviation. The middle-aged population is a significant sector driving market expansion, since they are more likely to be experiencing symptoms associated with GERD. Furthermore, it is anticipated that Dexlansoprazole's market share will increase as the region's healthcare infrastructure advances and more people have access to healthcare services. In summary, dexlansoprazole is an essential therapy choice in the management of GERD in Latin America, catering to the needs of various patient populations in the context of changing healthcare dynamics.

• According to Cognitive Market Research, the Brazil Dexlansoprazole market size was valued at USD XX million in 2024 and is projected to grow at a CAGR of 6.0% during the forecast period. Dexlansoprazole sales flourish in Brazil due to the nation's investments in healthcare infrastructure.
• The Argentina Dexlansoprazole market had a market share of USD XX million in 2024 and is projected to grow at a CAGR of 6.3% during the forecast period. The demand is augmented by Argentina's commitment rising demand for advanced medical.
• The Colombia Dexlansoprazole market is projected to witness growth at a CAGR of 5.2% during the forecast period with a market size of USD XX million in 2024.
• The Peru Dexlansoprazole market is projected to witness growth at a CAGR of 5.6% during the forecast period with a market size of USD XX million in 2024.
• The Chile Dexlansoprazole market is projected to witness growth at a CAGR of 5.7% during the forecast period with a market size of USD XX million in 2024.
• The Rest of Latin America Dexlansoprazole market is projected to witness growth at a CAGR of 4.5% during the forecast period with a market size of USD XX million in 2024.

Middle East and Africa Dexlansoprazole Market

According to Cognitive Market Research, the global Dexlansoprazole market size was estimated at USD XX Million out of which Middle East and Africa held the major market of around 2% of the global revenue with a market size of USD XX million in 2024 and will grow at a compound annual growth rate (CAGR) of 5.7% from 2024 to 2031. Growth in the prevalence of gastroesophageal reflux disease (GERD) and rising awareness of efficacious treatment alternatives are driving the market for dexlansoprazole in the Middle East and Africa. For individuals looking for long-term care, the extended-release formulation of dexlansoprazole offers consistent relief from GERD symptoms. The urban middle-class population is a noteworthy demographic that is driving market expansion. This group is increasingly embracing Western food habits and lifestyle patterns, which is associated with an increase in GERD cases. Additionally, it is anticipated that Dexlansoprazole's market share will increase as the region's healthcare infrastructure develops further and access to healthcare services increases. Finally, given the changing landscape of healthcare and changing lifestyles in the Middle East and Africa, dexlansoprazole is an essential treatment option for GERD patients.

• According to Cognitive Market Research, the GCC Countries Dexlansoprazole market size was valued at USD XX million in 2024 and is projected to grow at a CAGR of 6.5% during the forecast period. Dexlansoprazole sales flourish in the GCC Countries due to the region's strategic investments in healthcare expenditure.
• The Egypt Dexlansoprazole market is projected to witness growth at a CAGR of 6.0% during the forecast period with a market size of USD XX million in 2024.
• The South Africa Dexlansoprazole market is projected to witness growth at a CAGR of 6.7% during the forecast period with a market size of USD XX million in 2024. Dexlansoprazole sales flourish in the South Africa due to the region's strategic investments in healthcare research and advancements.
• The Turkey Dexlansoprazole market is projected to witness growth at a CAGR of 5.2% during the forecast period with a market size of USD XX million in 2024.
• The Nigeria Dexlansoprazole market is projected to witness growth at a CAGR of 4.8% during the forecast period with a market size of USD XX million in 2024.
• The Rest of MEA Dexlansoprazole market is projected to witness growth at a CAGR of 4.7% during the forecast period with a market size of USD XX million in 2024.

Dexlansoprazole Market Analysis

Dexlansoprazole Market Product Type Segment Analysis

According to Cognitive Market Research, 30 mg holds a prominent market share. Because of its potent acid suppression, this strength is appropriate for treating erosive esophagitis and controlling symptoms of gastroesophageal reflux disease (GERD). Due to its convenience and effectiveness, patients and healthcare professionals prefer the 30 mg formulation, which has increased the demand for and presence of dexlansoprazole in the market.

60 mg is the fastest-growing category over the forecast period. Because of the increased acid suppression that this larger dosage offers, it is especially useful for treating erosive esophagitis and treating severe gastroesophageal reflux disease (GERD) cases. Due to its potency and capacity to handle more severe symptoms, Dexlansoprazole's market growth and demand are driven by healthcare professionals' prescription of the 60 mg formulation.

• 30 mg
• 60 mg

The above Chart is for representative purposes and does not depict actual sale statistics. Access/Request the quantitative data to understand the trends and dominating segment of Dexlansoprazole Industry. Request a Free Sample PDF!

Dexlansoprazole Market Application Segment Analysis

According to Cognitive Market Research, Gastroesophageal Reflux Disease held the major market share over the forecast period. The increasing demand for Dexlansoprazole is largely due to the rising incidence of Gastroesophageal Reflux Disease (GERD). Because of its extended-release formulation and ability to effectively relieve GERD symptoms such as acid regurgitation and heartburn, dexlansoprazole is the medication of choice for patients who need long-term care. Growing awareness of the effects of GERD is fueling the market expansion for dexlansoprazole by growing demand for efficient treatment solutions.

Heal Erosive Esophagitis is the fastest-growing category over the forecast period. Dexlansoprazole is becoming more and more in demand because of its ability to treat erosive esophagitis, a severe symptom of gastroesophageal reflux disease (GERD). The extended-release formulation of dexlansoprazole helps heal erosive esophagitis-related esophageal damage by providing long-lasting acid control. The increasing market presence of Dexlansoprazole can be attributed to its role in encouraging esophageal healing, which is aided by the increased awareness of issues connected to GERD

• Gastroesophageal Reflux Disease
• Heal Erosive Esophagitis

The above Graph is for representation purposes only. This chart does not depict actual Market share.

Dexlansoprazole Patient Demographics Segment Analysis

According to Cognitive Market Research, Adults held the major market share over the forecast period. Since adults are the main victims of gastroesophageal reflux disease (GERD), the need for efficient treatments like Dexlansoprazole is growing. Thanks to its extended-release formulation and proven efficacy, dexlansoprazole is becoming increasingly popular among adult patients who want to treat their GERD symptoms over the long term.

Geriatric is the fastest-growing category over the forecast period. As people age, they become more vulnerable to the consequences of gastroesophageal reflux disease (GERD), which calls for efficient treatment choices such as Dexlansoprazole. The senior population favors Dexlansoprazole because of its extended-release formulation and effectiveness in treating GERD symptoms, which has led to the drug's market expansion.

• Adults
• Geriatric
• Pediatric

Dexlansoprazole Distribution Channel Segment Analysis

According to Cognitive Market Research, Hospital Pharmacies held the major market share over the forecast period. Hospital pharmacies are essential to the expanding market for dexlansoprazole because they make the drug more accessible to patients suffering from erosive esophagitis and gastroesophageal reflux disease (GERD). Hospital pharmacists play a crucial role as go-betweens for patients and healthcare professionals. They guarantee Dexlansoprazole's availability and distribution, supporting the drug's rising use and market expansion in successfully treating severe gastrointestinal disorders in hospital settings.

Retail Pharmacies is the fastest-growing category over the forecast period. The Dexlansoprazole market is growing significantly due in large part to the availability of this medication at retail pharmacies, which is handy for those with GERD and erosive esophagitis. Retail pharmacies fill prescriptions for Dexlansoprazole as easily accessible places of care, guaranteeing that patients receive medication promptly. Dexlansoprazole's availability and usage are increased by the extensive presence of retail pharmacies, which supports the drug's market expansion for the treatment of gastrointestinal disorders.

• Hospital Pharmacies
• Retail Pharmacies
• Online Pharmacies

Author's Detail

Manjiri Kanhere

Senior Research Associate at Cognitive Market Research

LinkedIn

Profile

Manjiri Kanhere is an experienced market researcher focused on the Pharma & Healthcare industry. With over 3+ years of experience, She has worked with major pharmaceutical companies and healthcare providers, helping them to understand market trends, identify new business opportunities, and develop effective sales & marketing strategies. Her expertise lies in the ability to analyze complex data sets and deliver insights that drive business decisions. At Cognitive Market Research, she handles the market research related to Pharma and healthcare industry.

Author's Conclusion